Open tender · Germany · Pharmaceutical products
Open house Arzneimittelrabattverträge zum Wirkstoff Rivaroxaban, nur Filmtabletten exkl. Wirkstärke 2,5 mg, ATC B01AF01
In EnglishOpen House medicinal product discount agreements for the active ingredient Rivaroxaban, only film tablets excluding strength 2.5 mg, ATC B01AF01
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse in Germany is inviting bids for “Open House medicinal product discount agreements for the active ingredient Rivaroxaban, only film tablets excluding strength 2.5 mg, ATC B01AF01”. Bids close on 31 July 2027, 23:59 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Non-exclusive discount contracts for Rivaroxaban tablets (excluding 2.5mg strength) from 01.10.2025 to 30.09.2027
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 3 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences